Alkermes | Investor Presentation Deck | 56 slides

Alkermes · 2023-06
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

3
coverage by narrative range · generated from this deck JSON

Slide inventory

56
every slide · same image gating as the playbook
01
Slide 1
front_matter
02
Includes company overview, forward-looking statement safe harbor, SEC filing information, non-GAAP definition, and trademark disclosures.front_matter
03
front_matter
04
summarize
Open slide detailBeat · Current Reality (Pain)
05
This is a classic 'preempt_rebuttal' style slide used in proxy contests to defend the incumbent board.summarize
Open slide detailBeat · Current Reality (Pain)
06
transition
Open slide detailBeat · Current Reality (Pain)
07
The slide uses a four-column layout to summarize key business pillars.summarize
Open slide detailBeat · Current Reality (Pain)
08
The slide uses a three-column layout to present strategic priorities, with a footer highlighting stock performance relative to peers.summarize
Open slide detailBeat · Future Vision (Gain)
09
transition
Open slide detailBeat · Future Vision (Gain)
10
The slide uses a numbered list format to map strategic pillars to specific results.summarize
Open slide detailBeat · Future Vision (Gain)Loop · Before After
11
The slide uses three bar charts to demonstrate superior performance of ALKS relative to benchmarks.compare_peers
Open slide detailBeat · Future Vision (Gain)Loop · Before After
12
The slide uses bar charts to demonstrate performance relative to an 'unaffected date' related to a shareholder activist event.compare_peers
Open slide detailBeat · Future Vision (Gain)Loop · Before After
13
The slide highlights a 50% improvement in valuation multiple despite a decline in the NBI index multiple.analyze_data
Open slide detailBeat · Evidence & ProofLoop · Before After
14
cite_precedent
Open slide detailBeat · Evidence & Proof
15
The slide highlights board changes, including specific appointments with shareholder support and the addition of diverse skill sets.introduce_nominees
Open slide detailBeat · Evidence & Proof
16
The slide uses a dual-axis timeline (top and bottom) to annotate events on a stock price chart.expose_contradiction
Open slide detailBeat · Evidence & Proof
17
The table categorizes products into 'Proprietary' and 'Royalty' streams.analyze_data
Open slide detailBeat · Evidence & ProofLoop · Mece Breakdown
18
The slide uses a mix of bar charts for annual revenue and a line chart for weekly prescription growth.analyze_data
Open slide detailBeat · Evidence & ProofLoop · Mece Breakdown
19
The slide uses a bar chart to show quarterly net sales growth from Q4'21 to Q1'23.analyze_data
Open slide detailBeat · Evidence & ProofLoop · Mece Breakdown
20
The slide uses donut charts to represent revenue composition and growth.analyze_data
Open slide detailBeat · Evidence & ProofLoop · Mece Breakdown
21
Uses a before-after comparison of drug development stages (Gantt-style pipeline).present_solution
22
summarize
23
The chart uses a break in the x-axis to transition from historical data (2020-2022) to future projections (2024-2025).analyze_data
24
The slide uses a chronological sequence to demonstrate management's effective handling of a major revenue threat.illustrate_case
25
The slide uses a hub-and-spoke diagram to show the core Alkermes business and a separate branch for the oncology spin-off.present_solution
26
The slide uses a two-column layout to contrast the board's strategic rationale with the specific value propositions of the resulting companies.frame_situation
27
transition
28
The slide uses a grid layout with headshots, biographical bullet points, and committee membership indicators.introduce_nominees
29
The slide uses a table-like structure to compare four board members.introduce_nominees
30
The slide uses a structured table format to map committees to their specific oversight domains.summarize
31
Includes a specific quote from an ISS recommendation regarding majority voting standards.summarize
32
Uses a before-after framing to show how shareholder feedback led to specific governance improvements.present_solution
33
transition
34
The slide uses a two-column layout to contrast engagement with two different activist investors.illustrate_case
35
This slide is part of a proxy contest defense, specifically attacking the credibility and suitability of the activist's nominees.preempt_rebuttal
36
The slide uses a two-column layout to contrast the 'Process' of board composition with the 'Decision Making' regarding specific nominees.introduce_nominees
37
The slide uses a red-themed table to highlight negative attributes of specific individuals.name_villain
38
The slide uses a table-like structure to present a timeline of legal events and critical court commentary.expose_contradiction
39
The slide uses a checkmark matrix to demonstrate board competency across five key areas: Neuroscience, Financial/Transactional, Commercial, Medical/R&D, and Glointroduce_nominees
40
This is a proxy fight slide comparing incumbent board members against challenger nominees.compare_peers
41
The slide uses a sidebar callout to emphasize the Board's role in initiating the transformation.summarize
42
This is a defensive slide in a proxy contest context, contrasting board achievements with criticisms of activist nominees.preempt_rebuttal
43
closing_ask
45
transition
46
Includes a diagram of brain pathways related to wakefulness and neurotransmitters.diagnose_problem
47
Includes a structural biology visualization of the Orexin 2 receptor.present_solution
49
Includes a CEO quote and specific program metrics.summarize
50
The slide uses a list of governance attributes on the left and three donut charts on the right to illustrate compensation design.present_framework
52
Values are in millions, unaudited.analyze_data
53
Financial disclosure table for Alkermes.analyze_data
54
Includes footnotes regarding weighted average shares and specific adjustments like share-based compensation, depreciation, and amortization.analyze_data
55
Includes a footnote regarding arbitration proceedings with Janssen Pharmaceutica N.V.analyze_data
56
state_next_steps